SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program

Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems

Intel VP: “We’re just not going to accept subpar products”

Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff

Buzz

Most popular

Daily

Weekly

1

“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals

2

Nice puts Actimize up for sale at a $1.5-2 billion price tag

3

Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers

4

Cybereason founders' 7AI raises record $130 million Series A in breakneck rise

5

Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ

NeuroDerm

3 stories about NeuroDerm

ירון ויצנבליט PWC הייטק

After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%

27.12.17|Amarelle Wenkert

U.S. buyers accounted for the majority of deals in 2017, with as many as 33 deals valued at $4.1 billion, according to a new report

מימין עודד ליברמן מנכל נוירודרם עם נציגי הרוכשת מיצובישי טנאבה

Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm

19.10.17|Lilach Baumer

NeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation

Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion

25.07.17|Gil Kalian

Osaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020